Venetoclax Monotherapy for Relapsed/Refractory Multiple Myeloma: Safety and Efficacy Results from a Phase I Study
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Shaji Kumar, Ravi Vij, Jonathan L. Kaufman, Joseph Mikhael, Thierry Facon, Brigitte Pegourie, Lofti Benboubker, Cristina Gasparetto, Martine Amiot, Philippe Moreau, Stefanie Alzate, Jeremy Ross, Martin Dunbar, Tu Xu, Suresh Agarwal, Joel Leverson, Paulo Maciag, Maria Verdugo, Cyrille Touzeau
Institutions: Mayo Clinic, Washington University in St. Louis, Emory University, Winship Cancer Institute, Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona), Centre Hospitalier Universitaire de Lille, Hôpital Claude Huriez, Centre Hospitalier Universitaire de Grenoble, Hôpital Albert Michallon, Centre Hospitalier Universitaire de Tours, Duke Medical Center, Centre Hospitalier Universitaire de Nantes, AbbVie (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2979520565